Cargando…
Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
W.B. Saunders
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930204/ http://dx.doi.org/10.1016/j.jcrc.2022.154203 |
| _version_ | 1784889003969871872 |
|---|---|
| author | Samorodnitsky, Sarah Castro-Pearson, Sandra Yang, Kaifeng Lotfi-Emran, Sahar Ingraham, Nicholas E. Bramante, Carolyn Geising, Sarah Jones, Emma K. Wacker, David Puskarich, Michael Lusczek, Elizabeth Safo, Sandra Tignanelli, Christopher J. |
| author_facet | Samorodnitsky, Sarah Castro-Pearson, Sandra Yang, Kaifeng Lotfi-Emran, Sahar Ingraham, Nicholas E. Bramante, Carolyn Geising, Sarah Jones, Emma K. Wacker, David Puskarich, Michael Lusczek, Elizabeth Safo, Sandra Tignanelli, Christopher J. |
| author_sort | Samorodnitsky, Sarah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9930204 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | W.B. Saunders |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99302042023-02-15 Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals Samorodnitsky, Sarah Castro-Pearson, Sandra Yang, Kaifeng Lotfi-Emran, Sahar Ingraham, Nicholas E. Bramante, Carolyn Geising, Sarah Jones, Emma K. Wacker, David Puskarich, Michael Lusczek, Elizabeth Safo, Sandra Tignanelli, Christopher J. J Crit Care Article W.B. Saunders 2023-04 2023-02-15 /pmc/articles/PMC9930204/ http://dx.doi.org/10.1016/j.jcrc.2022.154203 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Samorodnitsky, Sarah Castro-Pearson, Sandra Yang, Kaifeng Lotfi-Emran, Sahar Ingraham, Nicholas E. Bramante, Carolyn Geising, Sarah Jones, Emma K. Wacker, David Puskarich, Michael Lusczek, Elizabeth Safo, Sandra Tignanelli, Christopher J. Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title | Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title_full | Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title_fullStr | Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title_full_unstemmed | Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title_short | Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals |
| title_sort | proteomic pathways associated with developing severe disease for patients with covid-19: a biologic analysis of data from two multicenter randomized controlled trials encompassing 13 u.s. hospitals |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930204/ http://dx.doi.org/10.1016/j.jcrc.2022.154203 |
| work_keys_str_mv | AT samorodnitskysarah proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT castropearsonsandra proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT yangkaifeng proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT lotfiemransahar proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT ingrahamnicholase proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT bramantecarolyn proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT geisingsarah proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT jonesemmak proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT wackerdavid proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT puskarichmichael proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT lusczekelizabeth proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT safosandra proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals AT tignanellichristopherj proteomicpathwaysassociatedwithdevelopingseverediseaseforpatientswithcovid19abiologicanalysisofdatafromtwomulticenterrandomizedcontrolledtrialsencompassing13ushospitals |